Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Axonics, Medtronic
Axonics defeats Medtronic lawsuit in spine-stimulation patent trial
Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's patent rights in nerve-stimulation technology.
Axonics did not infringe Medtronic’s patents, jury rules
The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s patents with its r-SNM devices.
Jury rules for Axonics in Medtronic’s long-running neuromodulation patent lawsuit
A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run afoul of three patents held by the company’s main rival, Medt | The case is one of several intellectual property disputes between the medtech giant and Axonics—which is currently waiting to become a subsidiary of Boston Scientific.
Axonics gains after win in trial in patent dispute with Medtronic
Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding Medtronic nothing.
Jury says Axonics didn’t infringe on Medtronic patents
Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).
Jury sides with Axonics in Medtronic patent dispute
Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.
Medtronic loses $150M spine patent suit
California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three elements of its sacral neuromodulation technology and sought $150 million from the device manufacturer.
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the Central District of California.
MassDevice
1d
The top 10 urology device stories of 2024 so far
Urology Week 2024, which closes out Urology Awareness Month, is a good time to highlight the innovations in this space.
Orange County Business Journal
6d
Axonics Says Won Patent Case Against Medtronic
12 ceremony.
Axonics
Inc. (Nasdaq: AXNX), a maker of medical devices to treat incontinence, said a jury has returned a ...
Reuters
2d
Lawsuits News | Today's Latest Stories | Reuters
Medical device maker
Axonics
has convinced a jury in California federal court that it did not violate rival
Medtronic
's ...
3d
Medtronic Buy Rating Affirmed: Sustained Growth and Strong Pipeline Drive Positive Outlook
Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback